TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

PIPERACILLIN

PIPERACILLIN SODIUM
Infectious Disease Approved 2003-11-14
Jump to: Indications Approvals Trials Competitors Similar Safety Patents
2
Indications
--
Phase 3 Trials
22
Years on Market

Details

Status
Prescription
First Approved
2003-11-14
Routes
INJECTION
Dosage Forms
INJECTABLE

Companies

ISTITUTO BIO ITA SPA
Active Ingredient: PIPERACILLIN SODIUM

PIPERACILLIN Approval History

Loading approval history...

What PIPERACILLIN Treats

7 indications

PIPERACILLIN is approved for 7 conditions since its original approval in 2003. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Intra-abdominal Infections
  • Nosocomial Pneumonia
  • Skin and Skin Structure Infections
  • Female Pelvic Infections
  • Community-Acquired Pneumonia
  • Appendicitis
  • Peritonitis
Source: FDA Label

Drugs Similar to PIPERACILLIN

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
PIPERACILLIN SODIUM
7 shared
B BRAUN MEDICAL
Shared indications:
Intra-abdominal InfectionsNosocomial PneumoniaSkin and Skin Structure Infections +4 more
ZOSYN IN PLASTIC CONTAINER
PIPERACILLIN SODIUM
7 shared
Baxter
Shared indications:
Intra-abdominal InfectionsNosocomial PneumoniaSkin and Skin Structure Infections +4 more
ERTAPENEM SODIUM
ERTAPENEM SODIUM
3 shared
ACS DOBFAR SPA
Shared indications:
Intra-Abdominal InfectionsSkin and Skin Structure InfectionsCommunity-Acquired Pneumonia
INVANZ
ERTAPENEM SODIUM
3 shared
Merck
Shared indications:
Intra-Abdominal InfectionsSkin and Skin Structure InfectionsCommunity-Acquired Pneumonia
TIGECYCLINE
TIGECYCLINE
3 shared
Fresenius Kabi
Shared indications:
Skin and Skin Structure InfectionsIntra-abdominal InfectionsCommunity-Acquired Pneumonia
AMPICILLIN AND SULBACTAM
AMPICILLIN SODIUM
2 shared
EUGIA PHARMA SPECLTS
Shared indications:
Skin and Skin Structure InfectionsIntra-Abdominal Infections
CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER
CEFEPIME HYDROCHLORIDE
2 shared
B BRAUN
Shared indications:
Skin and Skin Structure InfectionsIntra-Abdominal Infections
CLARITHROMYCIN
CLARITHROMYCIN
2 shared
Teva
Shared indications:
Community-Acquired PneumoniaSkin and Skin Structure Infections
LIKMEZ
METRONIDAZOLE
2 shared
SAPTALIS PHARMS
Shared indications:
Intra-abdominal InfectionsPeritonitis
LINEZOLID
LINEZOLID
2 shared
SAGENT PHARMS INC
Shared indications:
Nosocomial PneumoniaCommunity-Acquired Pneumonia
LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
LINEZOLID
2 shared
Pfizer
Shared indications:
Nosocomial PneumoniaCommunity-Acquired Pneumonia
MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
MEROPENEM
2 shared
B BRAUN MEDICAL
Shared indications:
Skin and Skin Structure InfectionsIntra-abdominal Infections
TYGACIL
TIGECYCLINE
2 shared
PF PRISM CV
Shared indications:
Skin and Skin Structure InfectionsIntra-abdominal Infections
ZYVOX
LINEZOLID
2 shared
Pfizer
Shared indications:
Nosocomial PneumoniaCommunity-Acquired Pneumonia
ARIKAYCE KIT
AMIKACIN SULFATE
1 shared
INSMED INC
Shared indications:
Peritonitis
AVELOX
MOXIFLOXACIN HYDROCHLORIDE
1 shared
Bayer
Shared indications:
Skin and Skin Structure Infections
AZITHROMYCIN
AZITHROMYCIN
1 shared
Aurobindo Pharma
Shared indications:
Community-Acquired Pneumonia
CASPOFUNGIN ACETATE
CASPOFUNGIN ACETATE
1 shared
HENGRUI PHARMA
Shared indications:
Peritonitis
CEFAZOLIN AND DEXTROSE
CEFAZOLIN SODIUM
1 shared
B BRAUN
Shared indications:
Skin and Skin Structure Infections
CEFAZOLIN IN DEXTROSE
CEFAZOLIN SODIUM
1 shared
Baxter
Shared indications:
Skin and Skin Structure Infections
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

PIPERACILLIN FDA Label Details

Pro

Indications & Usage

Piperacillin and tazobactam for injection, for intravenous use is a combination of piperacillin, a penicillin-class antibacterial and tazobactam, a beta-lactamase inhibitor, indicated for the treatment of: Intra-abdominal infections in adult and pediatric patients 2 months of age and older Nosocomial pneumonia in adult and pediatric patients 2 months of age and older Skin and skin structure infections in adults Female pelvic infections in adults Community-acquired pneumonia in adults To reduce the development of drug-resistant bacteria and maintain the effectiveness of Piperacillin and tazobac...

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

FDA Approval: ANDA065114 → Label: DailyMed → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.